Spanish law may halt international vaccine collaborations

Spanish investigators warn that a national law governing research into foot-and-mouth disease could hinder international collaborations on the development of a vaccine for the veterinary pathogen.

Written byXavier Bosch
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of David Stuart

Spanish investigators warn that a national law governing research into foot-and-mouth disease could hinder international collaborations on the development of a vaccine for the veterinary pathogen. In a letter made public in March, 135 scientists urged the government to reconsider a law that they say prevents the country's leading foot-and-mouth disease research institute from studying the virus.

Their protest focuses on a Spanish "royal decree" published in November that aims to enact a 2003 European Commission directive to tackle foot-and-mouth disease. Scientists were surprised to find that the Madrid-based Center of Animal Health Research (CISA), which has a long tradition of foot-and-mouth disease research, was not listed in the decree as the national center. Instead, the Central Laboratory of Animal Health (LCV) near Madrid was listed as the only reference center authorized to manipulate live foot-and-mouth disease virus for any purpose.

Scientists in the 20 Spanish ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies